Likewise, this mechanism would explain the detrimental impact of CAVPENET on proliferation and migration ability, since decreased glycolytic metabolism and expression of HK2 were observed in CAVPENET-treated PCa cells. The gene discussed is HK2; the disease is posterior cortical atrophy.